Clinical Trials Logo

Clinical Trial Summary

The aim of this post-market clinical follow-up study is to evaluate the continued safety and performance of the marketed Evolution® Esophageal Stent System (Partially- and Fully Covered).

Clinical Trial Description

A retrospective observational, multi-center, chart review study will be performed. Data from all consecutive patients who underwent stent placement with any of the stents at the participating sites between 1st January 2018 and 31st December 2020 (index period) will be collected. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05182255
Study type Observational
Source Cook Group Incorporated
Contact Thomas Rhode Jorgensen
Phone +45 56868963
Email [email protected]
Status Not yet recruiting
Start date February 2022
Completion date October 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05054933 - Ultrasound Capsule Endoscopy for Esophagus Examination N/A
Completed NCT04090554 - Cytospongeâ„¢ Feasibility Study in Tanzania N/A
Active, not recruiting NCT03962179 - Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) N/A
Recruiting NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Recruiting NCT04481100 - CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer Phase 2
Completed NCT03859557 - The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
Completed NCT00977678 - Drop in Gastroscopy - Experience After 9 Months N/A
Completed NCT00874263 - Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies N/A
Terminated NCT00442507 - Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction Phase 2
Recruiting NCT03832959 - Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study. N/A
Withdrawn NCT02569073 - Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain Phase 4
Recruiting NCT00260585 - Esophageal Cancer Risk Registry
Completed NCT03187314 - Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer Phase 2
Recruiting NCT05004155 - Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
Recruiting NCT03267355 - Indications and Outcomes of Endoscopic Ultrasound in Tanta N/A
Recruiting NCT00939263 - Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index N/A
Terminated NCT00208936 - Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus Phase 2
Completed NCT02476513 - Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders N/A
Completed NCT02002078 - Caustic Esophageal Burns in Children and High Doses of Methylprednisolone Phase 4
Completed NCT01019993 - Non-dependent Lung High Frequency Positive Pressure Ventilation (HFPPV) and Right Ventricular Function Phase 1